Tech Company Financing Transactions

Merida Biosciences Funding Round

Merida Biosciences closed a $121 million Series A venture capital round on 4/9/2025. Backers included Bain Capital Life Sciences, BVF Partners and Third Rock Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

500 Technology Square
Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.meridabio.com

Email Address

[email protected]

Overview

To improve the lives of patients living with autoimmune and allergic diseases through the discovery and development of a new class of biotherapeutics which enable the selective, complete and durable elimination of the pathogenic antibodies that underpin these conditions.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Adam Townsend

        

Browse more venture capital transactions:

Prev: 4/9/2025: Rondah AI venture capital transaction
Next: 4/9/2025: Optise venture capital transaction

Share this article

About Database of VC Transactions

Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary